Read articles from Global

March 27, 2025 by gfn.tv

GFN News #144 | CHILE'S REGULATORY MAKEOVER | Featuring Ignacio Leiva

Chile's latest vaping bill has been met with cautious optimism from consumer advocates - but what does it actually contain? Ignacio Leiva joins us to elaborate on Chile's regulatory makeover, and what this means for vapers in the country!

March 26, 2025 by msnbc.com

Are Zyns FDA approved now? Yes, and here's why.

The FDA authorized the marketing of Zyn nicotine pouch products, sparking debates on regulations. Zyn, a tobacco-free pouch popular on social media, contains powdered nicotine. FDA approval was based on low toxicant levels and potential harm reduction benefits. Studies showed Zyn helped smokers quit, leading to FDA approval for public health benefits. The FDA's decision aligns with the Tobacco Control Act, aiming to provide less harmful nicotine options. Zyn's approval coincided with a proposed rule to reduce nicotine levels in cigarettes. Despite concerns, offering alternatives like Zyn for smokers could reduce health risks.

March 26, 2025 by daily-pouch.com

Pragmatism vs. Ideology: The Institute of Economic Affairs on the Future of Nicotine Pouches

The IEA paper discusses resistance to practical solutions due to political ideologies, focusing on harm reduction methods like nicotine pouches facing opposition, even from anti-smoking organizations. The report emphasizes the need for evidence-based policies over political biases to promote public health benefits. Media sensationalism and misinformation perpetuate unfounded fears around harm reduction products. The example of Sweden's success with snus and nicotine pouches highlights the potential benefits of evidence-driven approaches. Policymakers are urged to prioritize scientific evidence to support innovations in harm reduction and smoking cessation for a healthier future.

March 26, 2025 by regulatorwatch.com

Nicotine Paradox | Safer Than Smoking, But Still Under Attack | RegWatch

Nicotine doesn’t cause cancer—yet safer nicotine products like vapes and pouches remain under relentless attack. This, despite the role these products play in driving smoking rates to historic lows across the Western world. Why is the war on smoking turning into a war on nicotine? In this episode, Dr. Jonathan Foulds, Professor of Public Health Sciences and Psychiatry at Penn State University, joins us to unpack the contradictions at the heart of public health’s approach to nicotine.

March 25, 2025 by gfn.tv

GFN.TV Interviews #60 | DESTINED TO FAIL | How Study Design Distorts Vaping Science

Are vaping studies destined to fail? Research on e-cigarette health effects often includes former smokers—skewing results and misleading the public. Dr. Arielle Selya explores why flawed study designs, academic incentives, and NIH funding pressures shape the science on vaping and tobacco harm reduction.

March 25, 2025 by biomedcentral.com

Fanning the flame: analysing the emergence, implications, and challenges of Australia’s de facto war on Nicotine

This commentary analyzes Australia’s increasingly strict nicotine regulations, likening them to a de facto War on Nicotine. While traditional tobacco control measures have successfully reduced smoking rates, recent policies—such as higher tobacco taxes and a vape ban—have unintentionally fueled a growing black market. This has led to increased criminal activity, systemic violence, and health risks from unregulated nicotine products. The paper argues that Australia’s current approach may be causing more harm than good, similar to the unintended effects of drug prohibition. It advocates for a shift toward harm reduction, tax reforms, and improved access to safer nicotine alternatives for a more effective policy.

March 24, 2025 by filtermag.org

After 20 Years of Its Tobacco Treaty, the WHO Has Little to Celebrate

The World Health Organization commemorated the 20th anniversary of the Framework Convention on Tobacco Control (FCTC), the global health treaty with 182 member countries. Despite high ambitions, the FCTC has not significantly reduced smoking rates worldwide. The WHO's focus on nicotine, rather than harm reduction, has hindered progress, leading to secrecy in decision-making and the exclusion of alternative voices. The treaty rejects innovative harm reduction strategies like non-combustible nicotine products, despite evidence of their benefits. The WHO's anti-vaping stance, based on outdated views, has deprived millions of smokers of safer alternatives. A modernized approach, embracing harm reduction, is needed for effective global tobacco control.

March 21, 2025 by thecritic.co.uk

Is smoking cool again?

Smoking rates are increasing in some parts of England for the first time in nearly two decades, prompting calls for more investment in tobacco control. Higher tobacco taxes have led to a thriving black market, making smoking more affordable. Public misconception about vaping's harm versus smoking's poses a challenge. The looming tobacco and vape regulations may drive a resurgence in smoking, particularly among younger generations. The appeal of the forbidden fruit and influencers glamorizing smoking could play a role. The government's upcoming restrictions on vaping could further fuel this trend, potentially reversing anti-smoking efforts.

March 19, 2025 by news-medical.net

Electronic cigarettes may pose lower cardiovascular risks for people with HIV

UCLA-led research suggests electronic cigarettes may pose lower cardiovascular risks for those living with HIV compared to tobacco cigarettes. People with HIV smoke at higher rates, facing tobacco-related health disparities. Conducted with a novel laboratory model, the study found e-cigarettes are less likely to cause atherogenesis, a key factor in artery blockages. Dr. Middlekauff recommends switching to e-cigarettes as a harm reduction strategy; tobacco smoking is a leading cause of preventable cardiovascular death in the U.S. Larger clinical trials are needed to confirm these findings. This data could help reduce heart attack risks for people living with HIV.

March 19, 2025 by news-medical.net

Electronic cigarettes may pose lower cardiovascular risks for people with HIV

UCLA-led research suggests electronic cigarettes may pose lower cardiovascular risks for those living with HIV compared to tobacco cigarettes. People with HIV smoke at higher rates, facing tobacco-related health disparities. Conducted with a novel laboratory model, the study found e-cigarettes are less likely to cause atherogenesis, a key factor in artery blockages. Dr. Middlekauff recommends switching to e-cigarettes as a harm reduction strategy; tobacco smoking is a leading cause of preventable cardiovascular death in the U.S. Larger clinical trials are needed to confirm these findings. This data could help reduce heart attack risks for people living with HIV.